APL Healthcare Limited Fluoxetine Export Data — India (DGFT 2022–2026)

Name: APL Healthcare Limited Fluoxetine Export Records India — #9 Exporter, 73 Shipments, $3.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fluoxetine

India Pharmaceutical Trade Intelligence

$235.3M253 Suppliers101 CountriesHS 30049099

ExportsIndia → UNITED STATES65.6%India → CANADA12.9%

ImportsUNITED KINGDOM → India$6.7B GERMANY → India$738.6K

#1 Supplier: SIDMAK LABORATORIES

APL Healthcare Limited — Fluoxetine Exporter #9 | $3.6M Trade Value | TransData Nexus | TransData Nexus

APL Healthcare Limited — Fluoxetine Exporter Profile

Indian Pharmaceutical Exporter · #9 for Fluoxetine · $3.6M export value · DGFT Verified

APL Healthcare Limited is the #9 Indian exporter of Fluoxetine with $3.6M in export value and 73 verified shipments. APL Healthcare Limited holds a 1.5% market share in Fluoxetine exports across 1 countries. The company exports 17 pharmaceutical products worth $27.3M across 11 therapeutic categories.

APL Healthcare Limited — Fluoxetine Export Profile: Buyers & Destinations

APL Healthcare Limited Fluoxetine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Fluoxetine?

Country	Value	Shipments	Share
UNITED STATES	$50.2M	1,004	54.3%
UNITED KINGDOM	$19.2M	399	20.8%
CANADA	$6.5M	130	7.0%
SOUTH AFRICA	$3.8M	109

Who Are the Top Buyers of Fluoxetine from India?

Buyer	Country	Value	Orders
TIME-CAP LABS,	UNITED STATES	$2.7M	62
J. KNIPPER & COMPANY	UNITED STATES	$2.6M	117
DR. REDDYS LABORATORIES, INC	UNITED STATES	$2.3M	45
ORION CORPORATION,	FINLAND	$1.1M	23
TORRENT PHARMA INC,	UNITED STATES	$850.0K	17
AVET PHARMACEUTICALS INC C/O	UNITED STATES	$800.0K	16
BROWN AND BURK LIMITED	UNITED KINGDOM	$600.0K	12
ACCORD HEALTHCARE INC.,	CANADA	$600.0K	12
IMRES B.V.	NETHERLANDS	$350.0K	7
ACCORD HEALTHCARE INC,	CANADA	$200.0K	4

India's Fluoxetine is purchased by 522 buyers worldwide. The top buyer is TIME-CAP LABS, (UNITED STATES), followed by J. KNIPPER & COMPANY and DR. REDDYS LABORATORIES, INC.

How Does APL Healthcare Limited Compare to Nearest Fluoxetine Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	INTAS PHARMACEUTICALS LIMITED	$4.8M	97	7	$50.0K
8	DR.REDDY'S LABORATORIES LTD	$4.7M	172	7	$27.3K
9	APL HEALTHCARE LIMITED ★	$3.6M	73	1	$48.9K
10	CIPLA LIMITED	$3.0M	92	4	$32.5K
11	MEDREICH LIMITED	$2.2M	126	2	$17.5K

APL Healthcare Limited ranks #9 among 253 Indian Fluoxetine exporters. Average shipment value of $48.9K compared to the market average of $233.1K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and DR.REDDY'S LABORATORIES LTD.

Which Indian Ports Ship Fluoxetine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	603	16.3%
SAHAR AIR	508	13.7%
NHAVA SHEVA SEA (INNSA1)	285	7.7%
MUNDRA SEA	150	4.1%
MUNDRA SEA (INMUN1)	129	3.5%
Bombay Air	119	3.2%
DELHI AIR	110	3.0%
HYDERABAD ICD (INSNF6)	108	2.9%

Geopolitical & Trade Policy Impact on APL Healthcare Limited's Fluoxetine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like APL Healthcare. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)

Conversely, US-China trade tensions have prompted the United States to seek alternative pharmaceutical suppliers, potentially benefiting Indian exporters. However, the looming threat of US tariffs on pharmaceutical imports adds a layer of uncertainty. In March 2025, Indian pharma exports to the US surged by 74% amid tariff concerns, indicating proactive measures by exporters to mitigate potential impacts. (business-standard.com)

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers APL Healthcare an opportunity to strengthen its presence in the European market, provided it aligns with EU regulatory standards. (en.wikipedia.org)

APL Healthcare Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing sites as of 2024. (business-standard.com) This robust compliance framework enhances the credibility of Indian pharmaceuticals in global markets.

For APL Healthcare, maintaining and enhancing compliance with FDA, WHO, and EU GMP standards is crucial. Adherence to evolving quality requirements not only ensures market access but also builds trust with international partners. Continuous investment in quality assurance and regulatory affairs will be essential to navigate the complex global pharmaceutical landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: APL Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 101+ countries, 522+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fluoxetine

Fluoxetine

APL Healthcare Limited — Fluoxetine Exporter Profile

APL Healthcare Limited — Fluoxetine Export Profile: Buyers & Destinations

Where Does India Export Fluoxetine?

Who Are the Top Buyers of Fluoxetine from India?

What Is India's Total Fluoxetine Export Value and How Much Does APL Healthcare Limited Contribute?

What Is the Average Shipment Value for APL Healthcare Limited's Fluoxetine Exports?

How Does APL Healthcare Limited Compare to Other Indian Fluoxetine Exporters?

Regulatory Requirements: Exporting Fluoxetine to Key Markets

United States — FDA

United Kingdom — MHRA

How Does APL Healthcare Limited Compare to Nearest Fluoxetine Exporters?

Which Indian Ports Ship Fluoxetine Exports?

What Other CNS & Psychiatric Products Does APL Healthcare Limited Export?

Geopolitical & Trade Policy Impact on APL Healthcare Limited's Fluoxetine Exports

APL Healthcare Limited — Regulatory Compliance & Quality Standards

About APL Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fluoxetine Export Data from APL Healthcare Limited

Fluoxetine Stats

Company Overview

Top Products by APL Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source